日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model

NT-I7 是一种新型长效白细胞介素-7,可在自体人源化黑色素瘤模型中增强抗 PD-1 疗法的疗效。

Phoon, Yee Peng; Wolfarth, Alexandra A; Funchain, Pauline; Ko, Jennifer S; Choi, Donghoon; Dedkova, Eliska; Bateman, Daniela Duarte; Corvin, Jessica; Melenhorst, Jan J; Gastman, Brian R

Neurotoxicity after CTL019 in a pediatric and young adult cohort

CTL019 在儿童和青少年人群中的神经毒性

Gofshteyn, Jacqueline S; Shaw, Pamela A; Teachey, David T; Grupp, Stephan A; Maude, Shannon; Banwell, Brenda; Chen, Fang; Lacey, Simon F; Melenhorst, Jan J; Edmonson, MacKenzie J; Panzer, Jessica; Barrett, David M; McGuire, Jennifer L

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

嵌合抗原受体T细胞在难治性B细胞淋巴瘤中的作用

Schuster, Stephen J; Svoboda, Jakub; Chong, Elise A; Nasta, Sunita D; Mato, Anthony R; Anak, Özlem; Brogdon, Jennifer L; Pruteanu-Malinici, Iulian; Bhoj, Vijay; Landsburg, Daniel; Wasik, Mariusz; Levine, Bruce L; Lacey, Simon F; Melenhorst, Jan J; Porter, David L; June, Carl H

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

单次外周输注EGFRvIII靶向CAR-T细胞可导致复发性胶质母细胞瘤患者出现抗原丢失并诱导适应性耐药。

O'Rourke, Donald M; Nasrallah, MacLean P; Desai, Arati; Melenhorst, Jan J; Mansfield, Keith; Morrissette, Jennifer J D; Martinez-Lage, Maria; Brem, Steven; Maloney, Eileen; Shen, Angela; Isaacs, Randi; Mohan, Suyash; Plesa, Gabriela; Lacey, Simon F; Navenot, Jean-Marc; Zheng, Zhaohui; Levine, Bruce L; Okada, Hideho; June, Carl H; Brogdon, Jennifer L; Maus, Marcela V

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.

双重靶向 CD19 和 CD123 可防止 CD19 靶向免疫疗法后抗原丢失复发

Ruella Marco, Barrett David M, Kenderian Saad S, Shestova Olga, Hofmann Ted J, Perazzelli Jessica, Klichinsky Michael, Aikawa Vania, Nazimuddin Farzana, Kozlowski Miroslaw, Scholler John, Lacey Simon F, Melenhorst Jan J, Morrissette Jennifer J D, Christian David A, Hunter Christopher A, Kalos Michael, Porter David L, June Carl H, Grupp Stephan A, Gill Saar

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy

检测接受托珠单抗和/或司妥昔单抗治疗的CAR-T细胞疗法患者血清中的IL-6和sIL-6R水平

Chen, Fang; Teachey, David T; Pequignot, Edward; Frey, Noelle; Porter, David; Maude, Shannon L; Grupp, Stephan A; June, Carl H; Melenhorst, Jan J; Lacey, Simon F

CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.

由幼稚 T 细胞产生的 CMV 特异性 T 细胞可识别非典型表位,并可能在体内发挥保护作用

Hanley Patrick J, Melenhorst Jan J, Nikiforow Sarah, Scheinberg Phillip, Blaney James W, Demmler-Harrison Gail, Cruz C Russell, Lam Sharon, Krance Robert A, Leung Kathryn S, Martinez Caridad A, Liu Hao, Douek Daniel C, Heslop Helen E, Rooney Cliona M, Shpall Elizabeth J, Barrett A John, Rodgers John R, Bollard Catherine M

A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)

一项 I/III 期、多中心、开放标签试验,评估 talimogene laherparepvec (T-VEC) 与 pembrolizumab 联合治疗未切除的 IIIb-IV 期黑色素瘤的疗效 (MASTERKEY-265)

Botelho, Monica C; Alves, Helena; van de Ven, Rieneke; van Pul, Kim; Aliabadi, Shaghayegh; van den Tol, Petrousjka; te Velde, Lisette A; Rutgers, Emiel JTh; Vuylsteke, Ronald JCLM; Stockmann, Hein BAC; Dubay, Christopher; Harrington, Chris; Fox, Bernard A; de Gruijl, Tanja D; Erbe, Amy K; Wang, Wei; Kim, Kyung Mann; Carmichael, Laskeesha; Gallendberger, MIkayla; Hess, Dustin; Mendonca, Eneida A; Song, Yiqiang; Hank, Jacquelyn A; Chen, Su-Chun; Signoretti, Sabina; Atkins, Michael B; Carlson, Alexander; Mier, James; Panka, David; McDermott, David F; Sondel, Paul M; Galsky, Matthew D; Noah, Hahn; Starodub, Alexander; Hauke, Ralph J; Twardowski, Przemyslaw; Fleming, Mark; Qi, Jingjing; Sonpavde, Guru; Patel, Manishkumar; Zhu, Jun; Chippada-Venkata, Uma; Albany, Costantine; Wang, Li; Merad, Miriam; Oh, William; Bhardwaj, Nina; Gnjatic, Sacha; Kim-Schulze, Seunghee; Ruella, Marco; Barrett, David M; Kenderian, Saad S; Shestova, Olga; Hofmann, Ted J; Scholler, John; Lacey, Simon F; Melenhorst, Jan J; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David A; Hunter, Christopher A; Porter, David L; June, Carl H; Grupp, Stephan A; Gill, Saar; Gangadhar, Tara C; Hamid, Omid; Smith, David C; Bauer, Todd M; Wasser, Jeffrey S; Luke, Jason J; Balmanoukian, Ani S; Kaufman, David R; Zhao, Yufan; Maleski, Janet; Leopold, Lance; Gajewski, Thomas F; Long, Georgina V; Dummer, Reinhard; Ribas, Antoni; Puzanov, Igor; Michielin, Olivier; VanderWalde, Ari; Andtbacka, Robert HI; Cebon, Jonathan; Fernandez, Eugenio; Malvehy, Josep; Olszanski, Anthony J; Gajewski, Thomas F; Kirkwood, John M; Kuznetsova, Olga; Chen, Lisa; Kaufman, David R; Chou, Jeffrey; Hodi, F Stephen

The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor

造血干细胞移植过程中针对巨细胞病毒(CMV)的适应性免疫转移取决于供体中CMV特异性T细胞的特异性和表型。

Scheinberg, Phillip; Melenhorst, Jan J; Brenchley, Jason M; Hill, Brenna J; Hensel, Nancy F; Chattopadhyay, Pratip K; Roederer, Mario; Picker, Louis J; Price, David A; Barrett, A John; Douek, Daniel C

The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements

通过基于DNA的多重PCR检测TCRB基因重排,确定人CD4+CD25+Foxp3+细胞的克隆组成

Scheinberg, Phillip; Melenhorst, Jan J; Hill, Brenna J; Keyvanfar, Keyvan; Barrett, A John; Price, David A; Douek, Daniel C